Described herein are pharmaceutical packaging programs which avoid oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate medications, these kinds of methods which include a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to oxyg